Evidence map›Paper›PMID 25113031›Full record

ArticleThe Journal of cell biology2014

Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery.

Anar K Murphy, Michael Fitzgerald, Teresa Ro, Jee Hyun Kim, Ariana I Rabinowitsch, Dipanjan Chowdhury, Carl L Schildkraut, James A Borowiec

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anar K MurphyDepartment of Biochemistry and Molecular Pharmacology, New York University Cancer Institute, New York University School of Medicine, New York, NY 10016.
Michael FitzgeraldDepartment of Biochemistry and Molecular Pharmacology, New York University Cancer Institute, New York University School of Medicine, New York, NY 10016.
Teresa RoDepartment of Biochemistry and Molecular Pharmacology, New York University Cancer Institute, New York University School of Medicine, New York, NY 10016.
Jee Hyun KimDepartment of Biochemistry and Molecular Pharmacology, New York University Cancer Institute, New York University School of Medicine, New York, NY 10016.
Ariana I RabinowitschDepartment of Biochemistry and Molecular Pharmacology, New York University Cancer Institute, New York University School of Medicine, New York, NY 10016.
Dipanjan ChowdhuryDana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.
Carl L SchildkrautDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
James A BorowiecDepartment of Biochemistry and Molecular Pharmacology, New York University Cancer Institute, New York University School of Medicine, New York, NY 10016 James.Borowiec@nyumc.org.
New York University · USAlbert Einstein College of Medicine · USHarvard University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
DNA REPLICATION INITIATION SITES IN MAMMALIAN CELLSR01GM045751 · NIGMS · YESHIVA UNIVERSITY · PI SCHILDKRAUT, CARL L · 1992 to 2023
$13.4M
Molecular mechanism and relevance of microRNAs in DSB repair pathway choiceR01CA142698 · NCI · DANA-FARBER CANCER INST · PI CHOWDHURY, DIPANJAN · 2010 to 2019
$3.8M
Regulation of RPA Activity in DNA RepairR01GM083185 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BOROWIEC, JAMES A. · 2009 to 2014
$2.1M
NCI NIH HHS P30 CA016087NCI NIH HHS P30CA16087NCI NIH HHS R01 CA142698NCI NIH HHS R01CA142698NIGMS NIH HHS 5R01 GM045751NIGMS NIH HHS R01 GM045751NIGMS NIH HHS R01 GM083185
6 · The paper itself

Abstract

Phosphorylation of replication protein A (RPA) by Cdk2 and the checkpoint kinase ATR (ATM and Rad3 related) during replication fork stalling stabilizes the replisome, but how these modifications safeguard the fork is not understood. To address this question, we used single-molecule fiber analysis in cells expressing a phosphorylation-defective RPA2 subunit or lacking phosphatase activity toward RPA2. Deregulation of RPA phosphorylation reduced synthesis at forks both during replication stress and recovery from stress. The ability of phosphorylated RPA to stimulate fork recovery is mediated through the PALB2 tumor suppressor protein. RPA phosphorylation increased localization of PALB2 and BRCA2 to RPA-bound nuclear foci in cells experiencing replication stress. Phosphorylated RPA also stimulated recruitment of PALB2 to single-strand deoxyribonucleic acid (DNA) in a cell-free system. Expression of mutant RPA2 or loss of PALB2 expression led to significant DNA damage after replication stress, a defect accentuated by poly-ADP (adenosine diphosphate) ribose polymerase inhibitors. These data demonstrate that phosphorylated RPA recruits repair factors to stalled forks, thereby enhancing fork integrity during replication stress.

Indexed as

Ataxia Telangiectasia Mutated ProteinsBRCA2 ProteinCamptothecinCell Line, TumorChromatinCyclin-Dependent Kinase 2DNA-Binding ProteinsDNA DamageDNA RepairDNA ReplicationDNA, Single-StrandedFanconi Anemia Complementation Group N ProteinHumansHydroxyureaMultiprotein ComplexesNuclear ProteinsAtaxia Telangiectasia Mutated ProteinsATR protein, humanBRCA2 ProteinBRCA2 protein, humanCamptothecinCDK2 protein, humanChromatinCyclin-Dependent Kinase 2DNA-Binding ProteinsDNA, Single-StrandedFanconi Anemia Complementation Group N ProteinHydroxyureaMultiprotein ComplexesNuclear ProteinsNucleic Acid Synthesis InhibitorsPALB2 protein, humanPhosphoprotein PhosphatasesPoly(ADP-ribose) Polymerase Inhibitorsprotein phosphatase 4Replication Protein ARNA, Small InterferingRPA1 protein, humanRPA2 protein, humanTopoisomerase I InhibitorsTumor Suppressor Proteins

Identifiers

PMID25113031
PMCPMC4137056
OpenAlexW2168278385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.